Preethy Paul, Ph.D,MBA. is a Co-founder and board member of Anison Therapeutics. She is one of the key inventors behind the discovery. She is specialized in cell and molecular biology and has experience in studies relating to the evaluation of natural products for anti-HPV activity. She has been working in the Anisomelic acid project for more than 10 years and has 16 international publications and 3 patents.  She has project managing experience as she worked in 3 TUTLI projects in the past. She has also been coordinating the project tasks, looking through its implementation, writing project reports, preparing presentation material for the past few years as a part of working in TUTLI & Novo Nordisk projects.  She participated in 2 pitching competition in 2019 organized by Spark up Turku (Start-up pitching competition) & Business Finland (LiveScienceLive) and won first prize in both of them.